Correlation Between CytomX Therapeutics and Ovid Therapeutics
Can any of the company-specific risk be diversified away by investing in both CytomX Therapeutics and Ovid Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CytomX Therapeutics and Ovid Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CytomX Therapeutics and Ovid Therapeutics, you can compare the effects of market volatilities on CytomX Therapeutics and Ovid Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CytomX Therapeutics with a short position of Ovid Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of CytomX Therapeutics and Ovid Therapeutics.
Diversification Opportunities for CytomX Therapeutics and Ovid Therapeutics
0.41 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between CytomX and Ovid is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding CytomX Therapeutics and Ovid Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ovid Therapeutics and CytomX Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CytomX Therapeutics are associated (or correlated) with Ovid Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ovid Therapeutics has no effect on the direction of CytomX Therapeutics i.e., CytomX Therapeutics and Ovid Therapeutics go up and down completely randomly.
Pair Corralation between CytomX Therapeutics and Ovid Therapeutics
Given the investment horizon of 90 days CytomX Therapeutics is expected to under-perform the Ovid Therapeutics. In addition to that, CytomX Therapeutics is 1.42 times more volatile than Ovid Therapeutics. It trades about -0.28 of its total potential returns per unit of risk. Ovid Therapeutics is currently generating about -0.4 per unit of volatility. If you would invest 95.00 in Ovid Therapeutics on October 23, 2024 and sell it today you would lose (21.00) from holding Ovid Therapeutics or give up 22.11% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
CytomX Therapeutics vs. Ovid Therapeutics
Performance |
| Timeline |
| CytomX Therapeutics |
| Ovid Therapeutics |
CytomX Therapeutics and Ovid Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with CytomX Therapeutics and Ovid Therapeutics
The main advantage of trading using opposite CytomX Therapeutics and Ovid Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CytomX Therapeutics position performs unexpectedly, Ovid Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ovid Therapeutics will offset losses from the drop in Ovid Therapeutics' long position.| CytomX Therapeutics vs. Spero Therapeutics | CytomX Therapeutics vs. Instil Bio | CytomX Therapeutics vs. NextCure | CytomX Therapeutics vs. Assembly Biosciences |
| Ovid Therapeutics vs. CytomX Therapeutics | Ovid Therapeutics vs. Spero Therapeutics | Ovid Therapeutics vs. Instil Bio | Ovid Therapeutics vs. NextCure |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |